SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Pharmacy Practice
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Zimmerman, C.
Right arrow Search for Related Content
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Protecting the Pharmaceutical Supply Channel

Chris Zimmerman, CPP, CFE

AmerisourceBergen, Chesterbrook, Pennsylvania

Protecting and securing the pharmaceutical supply channel requires constant vigilance in cooperation with all partners in the channel: the manufacturer, the distributor, and the pharmacy as well as state and federal legislators and regulatory agencies. No one approach can protect and secure; rather, the pharmaceutical industry as a whole needs to adopt a combination of approaches to ensure the safety and integrity of the supply channel. Right now, the most secure way to ensure product integrity and patient safety is through a primary distribution system, also referred to as normal distribution. Primary distribution involves the movement of pharmaceuticals from the manufacturer to the wholesale distributor to the pharmacy. Going forward, some new technologies offer great promise. The industry needs to address all technology solutions, from secure product packaging to tracking techniques such as tags, holograms, and ultimately radio frequency identification. All of these begin with the manufacturer, require wholesaler involvement, and rely on the pharmacy. The movement of product must be secure and the highest level of vigilance maintained.

Key Words: Pharmaceutical • supply channel • counterfeit • medications • wholesalers

Journal of Pharmacy Practice, Vol. 19, No. 4, 236-238 (2006)
DOI: 10.1177/0897190006293516


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement